InvestorsHub Logo
Followers 3
Posts 789
Boards Moderated 0
Alias Born 01/22/2009

Re: medic/ff post# 21952

Thursday, 05/07/2009 5:57:38 PM

Thursday, May 07, 2009 5:57:38 PM

Post# of 58465
If we have a partner I am thinking .10 minimum till approval.

If the R/S goes through we are still ok in my eyes. The 2009 note holders have a dilution protection provision in it for themselves. Which in a way helps us but the R/S would just decrease our gains.

R/S voted down .05 to .10

Approval could be anywhere from .20 to 1.00 in my opinion.

All due to the how bad people want in and what our existing O/S is at that time.

Just my opinion factoring in all the data I can, others have theirs too. Personally I am not worried. This is not a normal penny stock. Lately I have used other cancer Biotechs for market cap valuation and that is even sketchy, due to Genasense being a big break through. If approved.

Anyway, I am not an expert.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.